The Respimat Soft Mist Inhaler, a Novel Inhaled Drug Delivery Device.

The Respimat Soft Mist Inhaler, a Novel Inhaled Drug Delivery Device. Conn Med. 2016 Jun-Jul;80(6):359-64 Authors: Perriello EA, Sobieraj DM Abstract Summary The Respimat SMI offers a novel delivery mechanism for the management of primarily COPD, but asthma as well. Presently, four different medications, as monotherapy or a combination of two active ingredients, are available using the Respimat SMI technology. Multiple studies have demonstrated safety and efficacy of these drugs when delivered via Respimat SMI. Patients tend to prefer the Respimat SMI over traditional inhaler devices, as it overcomes some of the disadvantages posed by traditional delivery devices. PMID: 27509644 [PubMed - in process]
Source: Connecticut Medicine - Category: Journals (General) Authors: Tags: Conn Med Source Type: research